source
- STAT+: Celcuity’s breast cancer drug approved, its firstFDA's new CBER chief promises normalcy, an weight loss drug without GLP-1s, and more biotech news from The ReadoutSTAT · 15d ago↗ source
- Deaths from coronary artery disease have fallen, but more progress is within reachManaging risk factors is the key to further progress in reducing deaths from coronary artery disease, a new study finds.STAT · 15d ago↗ source
- J&J touts Icotyde prescriptions, but not sales, in first full quarterJohnson & Johnson teased some details on Wednesday morning about how the launch of its expected blockbuster Icotyde performed in the second quarter. Without disclosing how much revenue the plaque p…Endpoints · 15d ago↗ source